DEXLANSOPRAZOLE — all Canadian products
8 DINs
4 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is DEXLANSOPRAZOLE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02529025 | APO-DEXLANSOPRAZOLE | APOTEX INC | Capsule (Delayed-Release) | Nasogastric; Oral | DEXLANSOPRAZOLE 60 MG | Marketed | |
| 02528991 | APO-DEXLANSOPRAZOLE | APOTEX INC | Capsule (Delayed-Release) | Oral; Nasogastric | DEXLANSOPRAZOLE 30 MG | Marketed | |
| 02354950 | DEXILANT | TAKEDA CANADA INC | Capsule (Delayed-Release) | Oral; Nasogastric | DEXLANSOPRAZOLE 30 MG | Marketed | |
| 02354969 | DEXILANT | TAKEDA CANADA INC | Capsule (Delayed-Release) | Nasogastric; Oral | DEXLANSOPRAZOLE 60 MG | Marketed | |
| 02523361 | DEXLANSOPRAZOLE | TAKEDA CANADA INC | Capsule (Delayed-Release) | Oral; Nasogastric | DEXLANSOPRAZOLE 60 MG | Cancelled Pre Market | |
| 02523353 | DEXLANSOPRAZOLE | TAKEDA CANADA INC | Capsule (Delayed-Release) | Oral; Nasogastric | DEXLANSOPRAZOLE 30 MG | Cancelled Pre Market | |
| 02536390 | DEXLANSOPRAZOLE | ALTIUS HEALTHCARE INC | Capsule (Delayed-Release) | Nasogastric; Oral | DEXLANSOPRAZOLE 30 MG | Cancelled Post Market | |
| 02536404 | DEXLANSOPRAZOLE | ALTIUS HEALTHCARE INC | Capsule (Delayed-Release) | Oral; Nasogastric | DEXLANSOPRAZOLE 60 MG | Cancelled Post Market |
Browse other molecules: